- Zinner SH, Mayer K.H. Sulfonamides and trimethoprim. In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and practice of infectious diseases, 5th edn. New York: Churchill Livingston; 2000. p. 1076–88.
- Guerrant RL, Wood SJ, Krongaard L, Reid RA, Hodge RH. Resistance among foecal flora of patients taking sulfamethox-azole-trimethoprim or trimethoprim alone. Antimicrob Agents Chemother 1981; 19: 33–8.
- Mavromanolakis E, Maraki S, Samonis G, Tselentis Y, Cranidis A. Effect of norfloxacin, trimethoprim-sulfomethoxazole and nitrofurantoin on faecal flora of women with recurrent urinary tract infections. J Chemother 1997; 9: 203–7.
- Fujita K, Sakata H, Yoshioka H. Selective inhibition of Enterobacteriaceae in faecal flora of children by oral trimetho-prim-sulfamethoxazole. Pediatr Infect Dis 1984; 3: 530–3.
- Gleckman R, Blagg N, Joubert DW. Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy 1981; 1: 14–20.
- Guamer F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512–9.
- Price DJ, Sleigh JD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet 1970; 2: 1213–5.
- Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37: 51–3.
- Holloway F. Prescribing for the long-term mentally ill. A study of treatment practices. Br J Psychiatry 1988; 152: 511–5.
Scandinavian Journal of Infectious Diseases
Volume 36, 2004 - Issue 10